Infection Control Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product & Service and End User : Global Opportunity Analysis and Industry Forecast, 2021-2028

Infection Control Market Size & Trends

The global infection control market size was valued at $32,613.75 million in 2020, and is projected to reach $38,616.77 million by 2028, registering a CAGR of 3.0% from 2021 to 2028. Infections are mainly caused by microorganisms such as virus, bacteria, and fungi or parasites. Infections can be of different types such as stomach and intestinal infections, lung & respiratory infections, eye infections, ear infections, hospital acquired infections (HAIs), skin infections, and sexually transmitted infections. These infections can be caused by the cross infection from surface and skin of patient, equipment, and healthcare staff. Different types of products and services available to control infections include sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products.

Increase in incidence of hospital-acquired infections, rise in number of surgical procedures that require high intensity infection prevention & control, surge in number of government awareness program to ensure high degree infection prevention, rise in geriatric population, and surge in cases of chronic diseases such as diabetes, obesity, cancer, heart and respiratory disorders are the major factors that are expected to drive the growth of the market. In addition, rise in need for sterilization and disinfection in hospitals & clinics, technological advancements in sterilization & disinfection equipment, surge in outsourcing of sterilization services among hospitals, pharmaceutical & medical device companies, increase in production of medical nonwovens and single-use products due to surge in cases of COVID-19 are expected to drive the growth of the infection control market. However, adverse effects of chemical disinfectants and concerns regarding the safety of reprocessed instruments are expected to restrain the growth of the infection control market. Conversely, rise in adoption of single use medical nonwovens and devices is expected to offer lucrative opportunities during the forecast period.

The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The infection control product manufacturers are expanding their production capacity to manufacture medical nonwoven and gloves products in response to the COVID-19 pandemic. Rise in the number of COVID-19 cases and surge in need for healthcare workers are expected to drive the demand for protective barrier products and disposable hospital supplies. Thus, COVID-19 infection uplifted growth and opportunities for manufacturers of infection control products during the forecast period.

Market Segmentation  

The infection control market is segmented into product & service, end user, and region. On the basis of product & service, the market is categorized into sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. By sterilization, the market is divided into sterilization product, contract sterilization services, sterilization consumables and accessories. The sterilization product segment is further classified into heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, and other sterilization equipment. The contract sterilization services segment is further divided into ethylene oxide sterilization, e-beam sterilization, gamma sterilization, and others. The sterilization consumables and accessories segment is further classified into sterilization indicators and packaging accessories. By cleaning & disinfection products, the market is divided into disinfectants, disinfectors equipment, and others. The disinfectants segment is further divided into wipes, liquids, and sprays. By protective barriers, the market is categorized into medical nonwoven and gloves. The medical nonwoven segment is further divided into surgical gowns, face masks, coveralls, and others. By end user, the market is categorized into hospitals & clinics, pharmaceutical & medical device companies, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment review 

On the basis of product & service, the protective barrier segment is the major revenue contributor, and is projected to grow significantly during the forecast period. Increase in public awareness toward personal hygiene, rise in number of surgeries, rise in adoption of medical nonwovens, such as face masks, surgical drapes, and gowns, due to the surge in COVID-19 cases, and increase in production of medical nonwoven products and gloves are the major factors that drive the growth of the infection control market. 

By end user, the hospitals & clinics segment is the major shareholder in the infection control market, owing to rise in volume of surgical procedures performed in hospitals, surge in prevalence of hospital-acquired infections (HAIs), increase in number of hospitals & clinics, and surge in geriatric population coupled with surge in cases of chronic diseases.

Snapshot of Asia-Pacific infection control market  

Asia-Pacific presents lucrative opportunities for key players operating in the infection control market, owing to increase in incidences of hospital-acquired infections in emerging economies, rise in adoption of sterilization and disinfection equipment, development of the R&D sector, rise in healthcare reforms, and technological advancements in medical device manufacturing, Moreover, rise in demand for medical nonwoven products, surge in funding from government and non-government sectors to create awareness about infection prevention & control, and presence of high population base contributes toward the growth of the market. Moreover, surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share is expected to drive the growth of the infection control market in the region.

Competitive Landscape

The key players profiled in this report include 3M Company, Belimed AG, Ecolab Inc, Fortive (Advanced Sterilization Products), Getinge AB, Matachana Group, Miele Group, MMM Group, Sotera Health Llc, and Steris Plc (Cantel Medical Corporation).

Key Benefits for Stakeholders

• The study provides an in-depth analysis of the infection control market size along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers infection control market analysis from 2020 to 2028, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global infection control market growth.

  Infection Control Market Report Highlights

Aspects	Details
By PRODUCT & SERVICE	Sterilization Sterilization product Heat sterilization equipment Low temperature sterilization equipment Radiation sterilization equipment Other sterilization equipment Contract sterilization services Ethylene oxide sterilization E-beam sterilization Gamma sterilization Others Sterilization consumables and accessories Sterilization indicators Packaging accessories
By Cleaning & Disinfection Products	Disinfectants Wipes Liquids Sprays Disinfectors equipment Others
By Protective Barriers	Medical Nonwoven Surgical gowns Face masks Coveralls Others Gloves Endoscope reprocessing products
By END USER	Hospitals & clinics Pharmaceutical & medical device companies Others
By Region	North America  (US, Canada, Mexico) Europe  (Germany, France, UK, Italy, Spain, rest of Europe) Asia-Pacific  (Japan, China, Australia, India, South Korea, rest of Asia-Pacific) LAMEA  (Brazil, Saudi Arabia, South Africa, rest of LAMEA)
Key Market Players	FORTIVE CORPORATION (ADVANCED STERILIZATION PRODUCTS)., SOTERA HEALTH INC., GENITGE AB., MATACHANA GROUP., BELIMED AG., STERIS PLC (CANTEL MEDICAL CORPORATION)., .ECOLAB INC., 3M COMPANY, MIELE GROUP. (STEELCO), MMM GROUP

Analyst Review

Infectious diseases and disorders are mainly caused by pathogenic microorganisms, such as viruses, and parasites or fungi bacteria. These diseases can be spread, indirectly or directly, from infected or non-sterilized medical or surgical equipment used to treat a person, or from presence in the infected environment of any healthcare facility. Infection control is the most preferred preventable measure, to prevent these infections.

The factors such as increase in incidences of hospital-acquired infections, surge in number of surgical procedures, growing medical device reprocessing industry, and rise in incidence of chronic diseases associated with surge in geriatric population are expected to drive the growth of the infection control market. Moreover, adoption of new technologies with advancements in the technology of infection control devices further boosts the growth of the market. However, adverse effects of chemical disinfectants and concerns regarding the safety of reprocessed instruments are expected to restrain the growth of the infection control market.
 

Author Name(s) : Sushant Terdale| Sagar Mukhekar | Roshan Deshmukh

Related Tags

• Surgical Equipment
• Disposable Medical Supplies
• Medical Imaging
• Infectious Disease Testing